Yahoo Web Search

  1. Ad

    related to: overweight stock

Search results

    • Down 57%, Is AbCellera Biologics a Buy on the Dip?

      Down 57%, Is AbCellera Biologics a Buy on the Dip?

      Motley Fool via Yahoo Finance· 16 hours ago

      The steep losses might seem surprising if you've been paying attention to Wall Street analysts who follow AbCellera Biologics. KeyBanc has an overweight...